The Pharmaceutical Journal
Vol 268 No 7189 p349-354
16 March 2002

This article
Reprint
Photocopy

News summary

Related websites
Official Journal of the American Academy of Neurology (www.neurology.org)

Hair loss with dopamine agonists

Two case reports of alopecia induced by dopamine agonists are described in the current issue of Neurology (2002;58:829). Both cases involve women treated with pramipexole (Mirapexin). The first noticed hair loss two months after starting treatment, which stopped within two weeks of a change in medication to ropinirole. In the second patient, hair loss continued after pramipexole was substituted with ropinirole and only stopped after ropinirole was replaced with levodopa treatment.